Mitrofanova, A., Molina, J., Santos, J. V., Guzman, J., Morales, X. A., Ducasa, G. M., . . . Fornoni, A. (2018). Hydroxypropyl-β-cyclodextrin protects from kidney disease in experimental Alport syndrome and focal segmental glomerulosclerosis. Kidney Int.
Chicago-stil citatMitrofanova, Alla, et al. "Hydroxypropyl-β-cyclodextrin Protects From Kidney Disease in Experimental Alport Syndrome and Focal Segmental Glomerulosclerosis." Kidney Int 2018.
MLA-referensMitrofanova, Alla, et al. "Hydroxypropyl-β-cyclodextrin Protects From Kidney Disease in Experimental Alport Syndrome and Focal Segmental Glomerulosclerosis." Kidney Int 2018.
Varning: dessa hänvisningar är inte alltid fullständigt riktiga.